Search - tctmd.com

Displaying 81 - 100 of 633

Sort: Relevancy | Date

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

L.A. McKeown

October 27, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Conference News EACTS 2024

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Yael L. Maxwell

October 21, 2024

News Daily News

Slight Uptick in Mortality With TAVI in Recent Years: TVT Registry

Caitlin E. Cox

October 18, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

Presentation EACTS 2024

Streamlining Transcatheter Mitral Valve Replacement Screening

Presenter: Martin Beyer

October 10, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Advertisement

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Slight Uptick in Mortality With TAVI in Recent Years: TVT Registry

AI-Based CT Can Accurately Screen Patients for TMVR

Streamlining Transcatheter Mitral Valve Replacement Screening

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

TCTMD’s Top 10 Most Popular Stories for August 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content